- Home
- MDBH vs ONCY Comparison
MDBH vs ONCY Comparison
Compare MDBH & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- ONCY
- Stock Information
- Founded
- MDBH 1997
- ONCY 1998
- Country
- MDBH United States
- ONCY Canada
- Employees
- MDBH N/A
- ONCY N/A
- Industry
- MDBH
- ONCY Pharmaceuticals and Biotechnology
- Sector
- MDBH
- ONCY Health Care
- Exchange
- MDBH Nasdaq
- ONCY Nasdaq
- Market Cap
- MDBH 39.3M
- ONCY 49.1M
- IPO Year
- MDBH 2023
- ONCY 1999
- Fundamental
- Price
- MDBH $3.80
- ONCY $0.34
- Analyst Decision
- MDBH
- ONCY Strong Buy
- Analyst Count
- MDBH 0
- ONCY 4
- Target Price
- MDBH N/A
- ONCY $4.33
- AVG Volume (30 Days)
- MDBH 6.0K
- ONCY 820.6K
- Earning Date
- MDBH 05-12-2025
- ONCY 05-14-2025
- Dividend Yield
- MDBH N/A
- ONCY N/A
- EPS Growth
- MDBH N/A
- ONCY N/A
- EPS
- MDBH 0.84
- ONCY N/A
- Revenue
- MDBH $3,574,131.00
- ONCY N/A
- Revenue This Year
- MDBH N/A
- ONCY N/A
- Revenue Next Year
- MDBH N/A
- ONCY N/A
- P/E Ratio
- MDBH $4.51
- ONCY N/A
- Revenue Growth
- MDBH N/A
- ONCY N/A
- 52 Week Low
- MDBH $3.61
- ONCY $0.34
- 52 Week High
- MDBH $12.00
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- MDBH 33.72
- ONCY 23.40
- Support Level
- MDBH $4.08
- ONCY $0.37
- Resistance Level
- MDBH $5.06
- ONCY $0.45
- Average True Range (ATR)
- MDBH 0.23
- ONCY 0.04
- MACD
- MDBH -0.04
- ONCY -0.01
- Stochastic Oscillator
- MDBH 13.10
- ONCY 0.50
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.